Sacubitril (AHU-377): High-Purity Pharmaceutical Intermediate for Cardiovascular Research and Development
Unlock advancements in cardiovascular therapy with high-purity Sacubitril, a critical intermediate for pharmaceutical innovation.
Get a Quote & SampleProduct Core Value
Sacubitril
Sacubitril, also known as AHU-377, is a pharmaceutical intermediate of exceptional quality, essential for the development of advanced cardiovascular medications. With a guaranteed purity of ≥99%, it serves as a foundational component for researchers and manufacturers focused on treating conditions like heart failure. Its reliable supply and precise specifications support critical drug discovery and production processes, making it a preferred choice for pharmaceutical R&D.
- Discover the critical role of Sacubitril 149709-62-6 purity in ensuring the efficacy of cardiovascular drugs.
- Source this vital AHU-377 pharmaceutical intermediate to accelerate your heart failure drug development pipeline.
- Order Sacubitril research grade to meet stringent R&D requirements and achieve reliable experimental outcomes.
- Explore the advantages of partnering with a Sacubitril manufacturer supplier dedicated to quality and consistency.
Product Advantages
Uncompromising Purity
Achieve superior research outcomes with Sacubitril boasting a purity of ≥99%, a key factor for accurate method validation and quality control in pharmaceutical applications.
Reliable Pharmaceutical Intermediate
Utilize AHU-377 as a trustworthy pharmaceutical intermediate, enabling efficient synthesis and formulation of critical cardiovascular therapies.
Supports Critical Research
Investigate heart failure and hypertension with confidence by using Sacubitril research chemical, known for its well-defined characteristics and consistent performance.
Key Applications
Pharmaceutical Research
Leverage the high-purity Sacubitril API for groundbreaking research in new drug development, particularly for cardiovascular diseases.
Drug Development
Utilize Sacubitril as a key building block in the synthesis and formulation processes of novel therapeutic agents.
Cardiovascular Treatment Advancements
Contribute to better patient outcomes by employing Sacubitril in the creation of next-generation treatments for heart conditions.
Chemical Synthesis
Employ Sacubitril for intricate chemical synthesis pathways, meeting the demanding requirements of the pharmaceutical industry.